Clinical Trials Browser

Phase 3 × Squamous Cell Carcinoma of Head and Neck × tislelizumab × Clear all

NCT06258811 2025-03-13

Neoadjuvant Immunochemotherapy for LAOSCC

Phase 3 Recruiting

Squamous Cell Carcinoma of Head and Neck